Yarbrough Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.63M Hold
11,898
0.2% 49
2025
Q4
$5.55M Hold
11,898
0.17% 50
2025
Q3
$5.07M Hold
11,898
0.16% 56
2025
Q2
$4.56M Hold
11,898
0.16% 55
2025
Q1
$4.11M Hold
11,898
0.18% 54
2024
Q4
$3.57M Hold
11,898
0.14% 60
2024
Q3
$4.84M Hold
11,898
0.2% 49
2024
Q2
$3.82M Hold
11,898
0.16% 55
2024
Q1
$3.97M Hold
11,898
0.17% 55
2023
Q4
$3.22M Hold
11,898
0.17% 63
2023
Q3
$2.93M Hold
11,898
0.17% 62
2023
Q2
$3.61M Hold
11,898
0.2% 58
2023
Q1
$3.14M Hold
11,898
0.26% 62
2022
Q4
$2.86M Hold
11,898
0.23% 59
2022
Q3
$2.19M Hold
11,898
0.17% 65
2022
Q2
$2M Hold
11,898
0.15% 66
2022
Q1
$2.98M Hold
11,898
0.17% 64
2021
Q4
$3.06M Buy
+11,898
New +$2.91M 0.16% 67

Other funds holding HCA

Yarbrough Capital's HCA Position: Q1 2026 in Review

Yarbrough Capital held its HCA Healthcare (HCA) position steady in Q1 2026 at 11,898 shares worth $5.63M. The position accounts for 0.2% of the portfolio, ranked #49.

Yarbrough Capital first reported a position in HCA in Q4 2021 and has held it in 18 quarters since. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Yarbrough Capital held 11,898 shares of HCA Healthcare worth $5.63M as of Q1 2026.
  • Yarbrough Capital left its HCA Healthcare share count unchanged in Q1 2026.
  • HCA Healthcare made up 0.2% of Yarbrough Capital's portfolio in Q1 2026, its #49 holding.
  • Yarbrough Capital first reported a position in HCA Healthcare in Q4 2021 and has held it in 18 quarters since.
  • 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Yarbrough Capital's 13F filing for Q1 2026, filed 14 Apr 2026.